Surepulse VS Cap Small REF: SP-160-A1 component of VS Newborn Heart Rate Monitor

FDA Device Recall #Z-1357-2026 — Class III — January 20, 2023

Recall Summary

Recall Number Z-1357-2026
Classification Class III — Low risk
Date Initiated January 20, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm SUREPULSE MEDICAL LTD
Location Nottingham, N/A
Product Type Devices
Quantity N/A

Product Description

Surepulse VS Cap Small REF: SP-160-A1 component of VS Newborn Heart Rate Monitor

Reason for Recall

Retroactively reported; Labeling contains incorrect sizing guide for Cap, a component of the heart rate monitor.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of CT, TX and the countries of United Kingdom of Great Britain and Northern Ireland, Netherlands, United Arab Emirates.

Lot / Code Information

DI Number: 05060550650013/Lot: 13816/00001 13817/00001 13818/00001 13819/00001 13820/00001 13821/00001 13822/00001 13823/00001 13824/00001 13825/00001 13826/00001 13827/00001 13828/00001 13829/00001 13830/00001 13831/00001 13832/00001 13833/00001 13834/00001 13835/00001 13836/00001 13837/00001 13838/00001 13839/00001 13840/00001

Other Recalls from SUREPULSE MEDICAL LTD

Recall # Classification Product Date
Z-1359-2026 Class III Surepulse VS Cap Large REF: SP-162-A1 compone... Jan 20, 2023
Z-1358-2026 Class III Surepulse VS Cap Medium REF: SP-161-A1 compon... Jan 20, 2023
Z-1356-2026 Class III Surepulse VS Cap Extra Small REF: SP-159-A1 c... Jan 20, 2023
Z-1360-2026 Class III Surepulse VS Cap Extra Large REF: SP-163-A1 c... Jan 20, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.